|
MINPP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.798900E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.705900E-02 |
| Normal-vs-Stage2 |
1.358850E-01 |
| Normal-vs-Stage3 |
2.439000E-04 |
| Normal-vs-Stage4 |
1.66600000000017E-05 |
| Stage1-vs-Stage2 |
9.738600E-01 |
| Stage1-vs-Stage3 |
1.518220E-02 |
| Stage1-vs-Stage4 |
3.362400E-03 |
| Stage2-vs-Stage3 |
1.304450E-01 |
| Stage2-vs-Stage4 |
4.118300E-02 |
| Stage3-vs-Stage4 |
3.468800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.188500E-04 |
| Normal-vs-AfricanAmerican |
3.516800E-01 |
| Normal-vs-Asian |
5.256900E-03 |
| Caucasian-vs-AfricanAmerican |
2.160400E-01 |
| Caucasian-vs-Asian |
7.936400E-01 |
| AfricanAmerican-vs-Asian |
3.378400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.417200E-04 |
| Normal-vs-Female |
2.543600E-03 |
| Male-vs-Female |
2.074200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.577570E-02 |
| Normal-vs-Age(41-60Yrs) |
7.824900E-04 |
| Normal-vs-Age(61-80Yrs) |
9.903500E-03 |
| Normal-vs-Age(81-100Yrs) |
3.933900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.152640E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.053400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.864200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.530600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.531800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.822200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.271700E-02 |
| Classical-VS-Follicular |
1.675230E-01 |
| Classical-VS-Other |
5.659400E-01 |
| Classical-VS-Normal |
3.618200E-03 |
| Tall-VS-Follicular |
1.055960E-02 |
| Tall-VS-Other |
7.394200E-01 |
| Tall-VS-Normal |
2.384400E-04 |
| Follicular-VS-Other |
3.958800E-01 |
| Follicular-VS-Normal |
2.493200E-01 |
| Other-VS-Normal |
6.940400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.784400E-03 |
| Normal-vs-N1 |
7.86760000037745E-07 |
| N0-vs-N1 |
1.720900E-03 |
|
|
